Status:
COMPLETED
A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to test the effect of MK-0941 as add-on therapy for participants taking metformin for type 2 diabetes.
Eligibility Criteria
Inclusion
- Patient has type 2 diabetes mellitus
- Between the ages of 18 and 70
Exclusion
- Patient has a history of type 1 diabetes mellitus or ketoacidosis.
- Patient is on a weight loss program and is not in the maintenance phase or is taking weight loss medication.
- Patient has had surgery within 30 days of starting the study or has planned major surgery during the study
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT00792935
Start Date
January 1 2009
End Date
February 1 2010
Last Update
December 17 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.